MicroRNA 4786 (MIR4786)

MicroRNA 4786 (MIR4786), also known as hsa-mir-4786, is a small, non-coding RNA molecule that primarily functions in post-transcriptional gene regulation. It exerts its regulatory effects by binding to complementary sequences, typically in the 3' untranslated regions (UTRs) of messenger RNA (mRNA) molecules, leading to their degradation or translational repression. MIR4786 has been extensively studied for its involvement in various human diseases, particularly in cancer, where it often acts as an oncogene. Its dysregulation has been linked to the promotion of critical cancer hallmarks, including enhanced cell proliferation, migration, invasion, and inhibition of apoptosis, by modulating diverse downstream signaling pathways. Due to its altered expression in disease states and its crucial regulatory roles, MIR4786 is considered a potential diagnostic and prognostic biomarker, as well as a promising therapeutic target for conditions like cancer.

Other names

hsa-mir-4786miR-4786miRNA-4786

As MIR4786 is often found to be overexpressed and act as an oncogene in various diseases, therapeutic strategies would primarily involve anti-miRNA oligonucleotides (antimiRs) or miRNA sponges. These agents are designed to bind to and inhibit the activity of MIR4786, thereby preventing its interaction with target mRNAs and leading to the de-repression or increased expression of its downstream target genes. Conversely, if MIR4786 were to act as a tumor suppressor and be downregulated, miRNA mimics could be used to restore its levels and re-establish its repressive effects on oncogenic targets.